Pharmanext expands its portfolio with 4 brands

From January 2023, Medis doo.’s OTC portfolio is represented by Pharmanext in Hungarian pharmaceutical and retail channels.
Gengigel brand family has been a dominant player in the gingivitis category and Defendyl in the immune strengthening category. The brands Waya and Rosacta are new entrants to the reflux and pain relief markets.